Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 6.07 is 59% below its 5-year average of 14.90, around the middle of its 5-year range (-121.79–142.61).
As of the fiscal period ended Wednesday, December 31, 2025. 132.38% above its 12-month average of -18.74.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
6.07
EARNINGS PER SHARE (EPS) AVG TTM
-18.74
EARNINGS PER SHARE (EPS) AVG 3Y
-45.28
EARNINGS PER SHARE (EPS) AVG 5Y
14.90
EARNINGS PER SHARE (EPS) AVG 10Y
15.38
EARNINGS PER SHARE (EPS) AVG 15Y
7.35
EARNINGS PER SHARE (EPS) AVG 20Y
4.62
CURRENT VS TTM AVG
+132.38%
CURRENT VS 3Y AVG
+113.41%
CURRENT VS 5Y AVG
-59.25%
CURRENT VS 10Y AVG
-60.52%
CURRENT VS 15Y AVG
-17.36%
CURRENT VS 20Y AVG
+31.36%
Bio-Rad Laboratories, Inc.
Market Cap
$8.50B
Earnings Per Share (EPS)
6.07
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$7.47B
Earnings Per Share (EPS)
-1.72
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
Market Cap
$7.31B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$9.74B
Earnings Per Share (EPS)
3.31
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$9.75B
Earnings Per Share (EPS)
23.83
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$10.31B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.37B
Earnings Per Share (EPS)
-7.29
TTM Avg
-6.79
3Y Avg
-1.56
5Y Avg
-0.26
Market Cap
$6.27B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$10.91B
Earnings Per Share (EPS)
-3.76
TTM Avg
-1.35
3Y Avg
4.03
5Y Avg
5.21
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.50B | 6.07 | -18.74 | -45.28 | 14.90 |
| Tempus AI, Inc. (TEM)vs › | $7.47B | -1.72 | -3.00 | -2.43 | -2.16 |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | -0.54 | -0.79 | -1.41 | -1.76 |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 3.31 | 3.18 | 3.37 | 3.47 |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 23.83 | 20.29 | 15.04 | 13.87 |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | 0.19 | 14.72 | 15.46 | 14.11 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.29 | -6.79 | -1.56 | -0.26 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | -0.09 | 0.57 | 0.18 | -0.06 |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | -3.76 | -1.35 | 4.03 | 5.21 |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 0.69 | 0.77 | 1.27 | 1.25 |
Trailing EPS (TTM)
$6.07
Forward EPS (Est.)
$9.04
P/E Ratio
51.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 27.87 |
| 2024-12-31 | -65.36 |
| 2023-12-31 | -21.82 |
| 2022-12-31 | -121.79 |
| 2021-12-31 | 142.61 |
| 2020-12-31 | 127.86 |
| 2019-12-31 | 58.93 |
| 2018-12-31 | 12.10 |
| 2017-12-31 | 4.12 |
| 2016-12-31 | 0.88 |
| 2015-12-31 | 3.74 |
| 2014-12-31 | 3.08 |
| 2013-12-31 | 2.72 |
| 2012-12-31 | 5.85 |
| 2011-12-31 | 6.39 |
| 2010-12-31 | 6.70 |
| 2009-12-31 | 5.28 |
| 2008-12-31 | 3.30 |
| 2007-12-31 | 3.48 |
| 2006-12-31 | 3.92 |
| 2005-12-31 | 3.13 |
| 2004-12-31 | 2.65 |
| 2003-12-31 | 3.00 |
| 2002-12-31 | 2.70 |
| 2001-12-31 | 1.79 |
| 2000-12-31 | 1.27 |
| 1999-12-31 | 0.49 |
| 1998-12-31 | 0.99 |
| 1997-12-31 | 0.67 |
| 1996-12-31 | 1.07 |
